Moderna

MRNANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$96.529 B

$241.79 -6.42%

Close of 6 Nov 2026

As of 6 Nov 2026, Moderna (MRNA) has a market capitalization of $96.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.94B

#1142 by revenue

Earnings

-$2.82B

Loss-making

Shares outstanding

404,620,975

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#1AmgenAMGN$249.2B
#2Gilead SciencesGILD$207.8B
#3ModernaMRNA$96.5B
#4Argenx SeARGX$55.8B
#5Revolution MedicinesRVMD$38.5B

What if Moderna were worth as much as…

Open the what-if tool →

Gold $28.2T

$70,727.29

Per share 293× higher

Bitcoin $1.53T

$3,826.93

Per share 15.8× higher

Apple $5.02T

$12,563.46

Per share 52.0× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for Moderna are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.